ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Wound dehiscence,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2,1,Device failure,Device issues NEC,Device issues,Prod,N
3,1,Device failure,Device issues NEC,Device issues,Prod,N
4,1,Device failure,Device issues NEC,Device issues,Prod,N
5,1,Device failure,Device issues NEC,Device issues,Prod,Y
6,1,Device failure,Device issues NEC,Device issues,Prod,N
7,1,Device failure,Device issues NEC,Device issues,Prod,N
8,1,Device failure,Device issues NEC,Device issues,Prod,N
9,1,Device failure,Device issues NEC,Device issues,Prod,N
10,1,Device failure,Device issues NEC,Device issues,Prod,N
10,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Device failure,Device issues NEC,Device issues,Prod,N
12,1,Device failure,Device issues NEC,Device issues,Prod,N
13,1,Device failure,Device issues NEC,Device issues,Prod,N
14,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,1,Device failure,Device issues NEC,Device issues,Prod,N
16,1,Device failure,Device issues NEC,Device issues,Prod,N
